Insuman Comb 30 Solostar (Insulin Human)

Insuman Comb 30 Solostar is a human insulin used in the management of diabetes mellitus and related metabolic disorders.

• Type 1 diabetes mellitus: provides basal and prandial insulin to achieve glycemic control.
• Type 2 diabetes mellitus: supplements endogenous insulin to lower elevated blood glucose.
• Diabetic ketoacidosis (adjunct therapy): contributes to rapid reduction of hyperglycaemia when combined with other insulin regimens.

• Insulin human binds to insulin receptors on cell membranes, activating the intrinsic tyrosine kinase activity of the receptor. This triggers intracellular signaling cascades that promote translocation of GLUT‑4 transporters to the plasma membrane, enhancing glucose uptake in muscle and adipose tissue, while suppressing hepatic gluconeogenesis and glycogenolysis, thereby lowering circulating glucose levels.

Insuman Comb 30 Solostar may be associated with a range of adverse reactions.

Common Side Effects

• Hypoglycaemia: symptoms of low blood sugar such as shakiness, sweating, and confusion.
• Injection‑site reactions: redness, swelling, or pain at the injection site.
• Lipodystrophy: localized thickening or loss of subcutaneous fat.
• Weight gain: modest increase in body weight due to improved glucose utilization.
• Mild allergic reactions: itching or rash at the site of administration.

Serious or Rare Side Effects

• Severe hypoglycaemia: loss of consciousness or seizures requiring immediate assistance.
• Anaphylactic reaction: rapid onset of breathing difficulty, swelling, and hypotension.
• Hypokalemia: low serum potassium levels, potentially causing cardiac arrhythmias.
• Insulin‑induced oedema: peripheral swelling, especially in the lower extremities.
• Serum insulin antibodies: rare immune response that may alter insulin effectiveness.
• Necrotising fasciitis: extremely rare but serious infection at injection sites.

When using Insuman Comb 30 Solostar, several safety considerations are recommended.

• Blood‑glucose monitoring: check levels frequently to avoid hypoglycaemia.
• Dose adjustment during illness: reduce or increase insulin based on carbohydrate intake and stress response.
• Renal impairment: use caution and consider lower doses as insulin clearance may be reduced.
• Concomitant hypoglycaemic agents: monitor for additive glucose‑lowering effects.
• Pregnancy and lactation: discuss risks and benefits with a healthcare professional.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Insuman Comb 30 Solostar can interact with several drug classes, influencing its efficacy or safety.

Major Interactions (Avoid)

• Beta‑blockers: may mask symptoms of hypoglycaemia, complicating detection.
• MAO‑inhibitors: can potentiate insulin’s glucose‑lowering effect, increasing hypoglycaemia risk.
• Sulfonylureas: additive hypoglycaemic effect may require dose reduction.

Moderate Interactions (Monitor Closely)

• Thiazide diuretics: may raise blood glucose, necessitating insulin dose adjustment.
• ACE inhibitors and ARBs: can enhance insulin sensitivity, modestly lowering glucose.
• Oral contraceptives: may affect insulin requirements during hormonal changes.
• Corticosteroids: increase insulin resistance, potentially requiring higher insulin doses.